about
Rural Asthma: Current Understanding of Prevalence, Patterns, and Interventions for Children and Adolescents.Adjuvants for allergy immunotherapeutics.The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces.Modeling Unobserved Heterogeneity in Susceptibility to Ambient Benzo[a]pyrene Concentration among Children with Allergic Asthma Using an Unsupervised Learning Algorithm.Innovations in asthma therapy: is there a role for inhaled statins?Association of epilepsy and asthma: a population-based retrospective cohort study.Socioeconomic and Environmental Predictors of Asthma-Related Mortality.Insights in Public Health: Could School-based Asthma Initiatives in Hawai'i Help Keep Kids in Class?The Burden of Pediatric Asthma.High health gain patients with asthma: a cross-sectional study analysing national Scottish data setsA multi-stakeholder perspective on asthma care in Canada: findings from a mixed methods needs assessment in the treatment and management of asthma in adultsComparison of clinical characteristics and management of asthma by types of health care in South KoreaRespiratory Infection Induce Release of Hepoxilin A and Histamine Production by Airway NeutrophilsNovel pharmacist-led intervention secures the minimally important difference (MID) in Asthma Control Test (ACT) score: better outcomes for patients and the healthcare providerBaseline patient factors impact on the clinical efficacy of benralizumab for severe asthmaBedroom Allergen Exposure Beyond House Dust MitesAsthma Clinics in Primary Healthcare Centres in Oman: Do they make a difference?Bifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltration
P2860
Q38686180-8297BD44-00AF-491E-94BD-28C19138A7F4Q39151158-0E873FBA-385B-4016-8615-90C819157485Q41159836-823BB185-CDA6-43EA-936F-40BB0D1BB509Q47565928-087434E1-C337-4DDE-8BAE-D33D6B59E9BEQ52633072-7BDFCF87-E95B-40CE-8A93-8B0AA53B8954Q55035770-CDA6D9D2-8B2D-4E59-8C92-47127F82BF75Q55117422-D4FA2136-595B-4ADA-B841-4D7426EBD34DQ55379993-1E98365E-285D-430A-9DC5-E3FDA88B38D6Q55514850-527396FF-7272-4048-A827-4F507DE1394DQ56889565-3163FDB5-2A76-403C-B736-335EF2C97077Q57158712-23472DB9-CB81-45C2-8487-1548E2076C18Q57211619-976B3E40-F828-4ACE-B049-A27862C7F05DQ58122060-220203AA-9E12-48F1-9881-24A24C5F99A4Q58567196-DE1B0132-4B7F-42EE-9833-715BF1AF1C35Q58723876-0801203C-8198-4FFB-AFAE-F32B4D535562Q58731936-79199EE4-250B-4C16-8BC7-37254629E7C0Q58757257-F44A2587-4079-456C-9CA4-A1C1FBAE882CQ58786962-4B173183-9B78-426F-B318-B8B568891C7A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Asthma costs and social impact.
@en
Asthma costs and social impact.
@nl
type
label
Asthma costs and social impact.
@en
Asthma costs and social impact.
@nl
prefLabel
Asthma costs and social impact.
@en
Asthma costs and social impact.
@nl
P2093
P2860
P1476
Asthma costs and social impact.
@en
P2093
Ana Margarida Pereira
Carlos Nunes
Mário Morais-Almeida
P2860
P2888
P356
10.1186/S40733-016-0029-3
P577
2017-01-06T00:00:00Z
P6179
1046997215